GLP-1 Receptor Agonists Reduce Substance use Disorder: a Role for Addiction to Chemsex Drugs?@“ŠeŽÒFVeronique “Še“úF2026/08/25(Tue) 13:32:06 No.72829 [•ÔM] 
Searches for GLP-1 weight-loss patches have surged as public interest in medical weight-loss solutions continues to grow. Online adverts and social media posts now promote adhesive patches that claim to replicate the appetite-suppressing effects of prescription drugs such as Ozempic and Wegovy , without injections or GP appointments. However, health experts warn that many of these claims are misleading and lack scientific backing. A closer look at the evidence shows a clear gap between marketing promises and medical reality. GLP-1 weight-loss patches are sold over the counter and applied directly to the skin. Advertisements suggest they work by releasing ingredients that "mimic" glucagon-like peptide-1 (GLP-1), a hormone that helps regulate appetite and blood sugar. A recent Yahoo Finance report states that marketers often promote these patches as a non-prescription alternative to clinically approved GLP-1 medications. They appeal to consumers seeking rapid weight loss without medical oversight. In reality, these products do not contain prescription GLP-1 drugs. Instead, manufacturers typically rely on plant extracts, vitamins, or stimulants they claim support metabolism or reduce hunger. |
|